#Flash: Reliance Life Covid Vaccine Gets SEC Nod for Clinica
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Reliance Life gets Subject Expert Committee (SEC) nod for clinical trials of 2-dose Covid vaccine. After SEC nod, the company must first obtain clearance from the DCGI, after which it may begin Phase 1 trials of the COVID-19 vaccine. The trials will take place at ten different locations throughout India. The Covid vaccine would be "competitively priced."

If you find this article insightful, please like, comment and share.

For more detail please read here: https://www.bmj.com/content/373/bmj.n1005

https://www.livemint.com/news/india/reliance-life-gets-sec-nod-for-clinical-trials-of-2-dose-covid-19-vaccine-11630053966706.html
Dr. T●●●●z H●●●●●●i and 1 others like this1 share
Like
Comment
Share